Susquehanna International Group’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.93M | Sell |
1,822,600
-1,539,800
| -46% | -$8.64M | ﹤0.01% | 3131 |
|
|
2025
Q4 | $23.5M | Buy |
3,362,400
+786,800
| +31% | +$6.16M | ﹤0.01% | 2040 |
|
|
2025
Q3 | $19.9M | Buy |
2,575,600
+584,700
| +29% | +$4.56M | ﹤0.01% | 2213 |
|
|
2025
Q2 | $17.3M | Buy |
1,990,900
+385,000
| +24% | +$2.79M | ﹤0.01% | 2158 |
|
|
2025
Q1 | $12.8M | Buy |
1,605,900
+287,800
| +22% | +$2.91M | ﹤0.01% | 2224 |
|
|
2024
Q4 | $12M | Buy |
1,318,100
+836,900
| +174% | +$8.08M | ﹤0.01% | 2435 |
|
|
2024
Q3 | $4.42M | Sell |
481,200
-369,800
| -43% | -$3.06M | ﹤0.01% | 3802 |
|
|
2024
Q2 | $8.32M | Sell |
851,000
-317,100
| -27% | -$3.87M | ﹤0.01% | 2730 |
|
|
2024
Q1 | $17.6M | Buy |
1,168,100
+399,100
| +52% | +$7.24M | ﹤0.01% | 1921 |
|
|
2023
Q4 | $16.6M | Sell |
769,000
-193,000
| -20% | -$3.56M | ﹤0.01% | 2003 |
|
|
2023
Q3 | $17.9M | Buy |
962,000
+210,000
| +28% | +$4.9M | ﹤0.01% | 1862 |
|
|
2023
Q2 | $19M | Sell |
752,000
-130,500
| -15% | -$3.28M | ﹤0.01% | 1768 |
|
|
2023
Q1 | $22.9M | Sell |
882,500
-13,800
| -2% | -$369K | ﹤0.01% | 1573 |
|
|
2022
Q4 | $21.2M | Sell |
896,300
-102,000
| -10% | -$2.75M | 0.01% | 1467 |
|
|
2022
Q3 | $25.3M | Sell |
998,300
-1,003,700
| -50% | -$35.2M | 0.01% | 1220 |
|
|
2022
Q2 | $66.5M | Sell |
2,002,000
-569,300
| -22% | -$24.2M | 0.02% | 698 |
|
|
2022
Q1 | $185M | Sell |
2,571,300
-757,600
| -23% | -$54.6M | 0.03% | 418 |
|
|
2021
Q4 | $306M | Sell |
3,328,900
-363,100
| -10% | -$43.4M | 0.05% | 338 |
|
|
2021
Q3 | $468M | Sell |
3,692,000
-758,600
| -17% | -$110M | 0.06% | 251 |
|
|
2021
Q2 | $740M | Buy |
4,450,600
+623,700
| +16% | +$101M | 0.1% | 146 |
|
|
2021
Q1 | $696M | Buy |
3,826,900
+573,900
| +18% | +$133M | 0.11% | 140 |
|
|
2020
Q4 | $650M | Buy |
3,253,000
+1,044,100
| +47% | +$212M | 0.11% | 134 |
|
|
2020
Q3 | $484M | Buy |
2,208,900
+1,175,000
| +114% | +$249M | 0.09% | 157 |
|
|
2020
Q2 | $197M | Buy |
1,033,900
+449,500
| +77% | +$78.8M | 0.05% | 304 |
|
|
2020
Q1 | $90.6M | Buy |
584,400
+176,500
| +43% | +$20.5M | 0.03% | 421 |
|
|
2019
Q4 | $34.1M | Sell |
407,900
-52,700
| -11% | -$4.01M | 0.01% | 1032 |
|
|
2019
Q3 | $31.2M | Buy |
460,600
+124,200
| +37% | +$8.17M | 0.01% | 1012 |
|
|
2019
Q2 | $22.3M | Buy |
336,400
+24,000
| +8% | +$1.4M | 0.01% | 1200 |
|
|
2019
Q1 | $17.4M | Buy |
312,400
+68,700
| +28% | +$4.19M | 0.01% | 1293 |
|
|
2018
Q4 | $12.1M | Sell |
243,700
-79,300
| -25% | -$4.85M | ﹤0.01% | 1435 |
|
|
2018
Q3 | $27.9M | Buy |
323,000
+79,600
| +33% | +$5.67M | 0.01% | 1066 |
|
|
2018
Q2 | $14.1M | Buy |
243,400
+59,900
| +33% | +$2.93M | ﹤0.01% | 1609 |
|
|
2018
Q1 | $7.39M | Sell |
183,500
-171,000
| -48% | -$6.46M | ﹤0.01% | 2091 |
|
|
2017
Q4 | $12.4M | Buy |
354,500
+263,700
| +290% | +$8.76M | ﹤0.01% | 1657 |
|
|
2017
Q3 | $3.01M | Sell |
90,800
-34,400
| -27% | -$1.13M | ﹤0.01% | 3233 |
|
|
2017
Q2 | $4.34M | Buy |
125,200
+14,000
| +13% | +$408K | ﹤0.01% | 2594 |
|
|
2017
Q1 | $2.78M | Buy |
111,200
+40,700
| +58% | +$847K | ﹤0.01% | 3153 |
|
|
2016
Q4 | $1.16M | Sell |
70,500
-2,200
| -3% | -$37.4K | ﹤0.01% | 5194 |
|
|
2016
Q3 | $1.33M | Buy |
72,700
+31,200
| +75% | +$547K | ﹤0.01% | 4260 |
|
|
2016
Q2 | $665K | Buy |
41,500
+6,700
| +19% | +$78.2K | ﹤0.01% | 5626 |
|
|
2016
Q1 | $334K | Sell |
34,800
-100
| -0.3% | -$1.42K | ﹤0.01% | 7093 |
|
|
2015
Q4 | $627K | Buy |
+34,900
| New | +$644K | ﹤0.01% | 6345 |
|
Other funds holding TDOC
VPM
VCM
VC
Susquehanna International Group's TDOC Position: Q1 2026 in Review
Susquehanna International Group reduced its Teladoc Health (TDOC) stake by 17% in Q1 2026, selling an estimated $987K and leaving 885,526 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4299.
Susquehanna International Group first reported a position in TDOC in Q3 2016 and has held it in 36 quarters since. The position peaked at $241M in Q1 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Susquehanna International Group held 885,526 shares of Teladoc Health worth $4.83M as of Q1 2026.
- Susquehanna International Group sold 175,942 Teladoc Health shares in Q1 2026, an estimated $987K.
- Teladoc Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4299 holding.
- Susquehanna International Group first reported a position in Teladoc Health in Q3 2016 and has held it in 36 quarters since.
- Susquehanna International Group's Teladoc Health position peaked at $241M in Q1 2021.
- 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.